GlobeNewswire Inc | Feb 4, 2021 07:00AM EST

February 04, 2021

LONDON, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc(Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its fourth quarter and full year 2020 financial results and operational highlights before open ofU.S.markets onThursday, March 4, 2021.

Management will host a conference call and webcast at8:30 am ET/1:30 pm GMT to discuss the companys financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to the events section of Autolus website

The call may also be accessed by dialing (866) 679-5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 2268057. After the conference call, a replay will be available for one week. To access the replay, please dial (855) 859-2056 for U.S. and Canada callers or (404) 537-3406 for international callers. Please reference conference ID 2268057.

Contact:

Lucinda Crabtree, PhDVice President, Investor Relations and Corporate Communications+44 (0)7587 372 619l.crabtree@autolus.com

Julia Wilson+44 (0) 7818 430877j.wilson@autolus.comSusan A. NoonanS.A. Noonan Communications+1-212-966-3650susan@sanoonan.com